Skip to main content

Table 1 Patients’ clinical features and laboratory results

From: Hypereosinophilia in childhood acute lymphoblastic leukaemia at diagnosis: report of 2 cases and review of the literature

Characteristics

Patient #1

Patient #2

Sex

Female

Male

Age at diagnosis

13 years

20 months

Peripheral blood:

  

Hb (g/dL)

9.8

12

White blood cells count (μL)

7,870

14,390

Eosinophils count (μL)(%)

3,490 (44.3%)

4,620 (32.1%)

Platelets count (μL)

129,000

223,000

Blasts (%)

None

2

Bone marrow aspirate:

  

Blasts (%)

52

60

Eosinophils (%)

30

36

FAB classification

L2

L1

Immunophenotype

Common

Common

DNA index

1

1,1

Bone marrow biopsy

B cells lymphoproliferative syndrome; MF1 (WHO grading)

B cells lymphoproliferative syndrome; MF0 (WHO grading)

Karyotype

46, XX

Hyperdiploid (52,XXY,+6,+14,+17,+21,+21[5])

Molecular biology for ALL rearrangements

Negative

Negative

Molecular biology for thrombophilia

Positive (Homozygous for -455G/A of b-fibrinogen)

Positive (Eterozygous for P1b of HPA)

Clinical presentation

Evening fever

Night sweat

 

Left iliac-femoral deep venous thrombosis

Fever

  

Pruritic erythroderma

  

Claudication for left inferior limb arthralgia

Other organ involvement

No

Skin

  

Bone (tibial osteolysis)

  1. FAB, French-American-British classification; MF, myelofibrosis; WHO, world health organization; HPA, human platelet antigen; ALL, acute lymphoblastic leukaemia.